TITAN PHARMACEUTICALS INC — key financial figures for fiscal year 2024 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2024)

-$4.7M

Total Assets (FY2024)

$2.9M

Total Equity (FY2024)

$2.4M

Cash Flows from Operating Activities (FY2024)

-$3.9M

Source: TITAN PHARMACEUTICALS INC 10-K filing (FY2024). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.